Investment Team
Partner, Co-Head Flagship Fund
Judith joined Astorg in 2009 and leads the Healthcare team. She is a member of the Flagship Fund Executive Committee and of the Investment Committee.
Prior to joining Astorg, Judith worked in Investment Banking at Morgan Stanley, in Paris and New York.
Judith is an ESSEC graduate and holds a Master in Political Science from Paris I Panthéon-Sorbonne University.
OPEN Health
OPEN Health is a global leading medical affairs and market access platform serving the pharma industry.
Investment year: 2022
Sustainable development goals:
CordenPharma
CordenPharma is a leading CDMO focused on fast-growing complex niche drug modalities with end to end capabilities from early stage development to commercial large-scale manufacturing.
Investment year: 2022
Sustainable development goals:
Cytel
Cytel is widely recognized as the industry pioneer of adaptive clinical trials technology and a thought-leader in biostatistical science.
Investment year: 2021
Sustainable development goals:
Demetra
Demetra is a world-leading player in the bone cement and biomaterials space, serving all the major players in the orthopaedic industry.
Investment year: 2021
Sustainable development goals:
Clario
Clario delivers leading endpoint technology solutions for clinical trials.
Investment year: 2020
Sustainable development goals:
Echosens
Echosens is a specialized diagnostic company providing non-invasive medical devices and services to support physicians in their diagnostic and monitoring of chronic liver diseases.
Investment year: 2018
Sustainable development goals:
HRA Pharma
HRA is an innovative OTC pharma company with leading positions in Europe and in the US.
Investment year: 2016
Sustainable development goals:
IQ-EQ
IQ-EQ is a leading investor services group providing a comprehensive range of services to investment funds, global companies, family offices and private clients globally.
Investment year: 2016
Sustainable development goals:
